Procter & Gamble Hygiene & Health Care fell by 1.65 per cent to Rs 14,357.05 after the company’s net profit slipped by 13.12 per cent to Rs 42.55 crore on a 1.3 per cent decline in net sales to Rs 776.38 crore in June 2022 over June 2021. According to the company, the PAT was largely due to the commodity cost of inflation. Quarterly, both feminine care and healthcare business continue to maintain their leader category.

Profit before tax (PBT) declined 14.2 per cent yearly to Rs 57.70 crore, while the cost of materials consumed slumped 16.7 per cent yearly to Rs 210.71 crore at the end of the first quarter. The consolidated net profit of P&G hygiene fell by 11.67 per cent to Rs 575.75 crore. Despite net sales at 9.14 per cent to Rs 3,900.92 crore at the end of the first quarter.

• LNG Imports in India Surged 10.5% During October 
• US Climate Financing Reaches $11 Billion in 2024
• Govt Likely to Surpass FY25 Direct Tax Target: CBDT Chief
• RVNL Receives Rs 295 Crore Contract from South Central Railway, Shares Trading Flat
• ACME Solar Shares Hit 10% Upper Circuit as Subsidiary Secures Rs 3,953 Crore Loan  

LV Vaidyanathan, managing director of Procter & Gamble Hygiene and Health Care, said, “The operating environment continues to be marked by unprecedented headwinds and commodity fluctuations. Despite these challenges, we remain resilient, agile, and committed to serving Indian consumers, delivering sequential sales growth this year. The execution of our integrated strategies of a strong portfolio, superiority, productivity, constructive disruption, and an agile and accountable organisational structure has empowered us to deliver these consistent results. Our strategy is fueled by balancing innovation and industry-leading practices while driving productivity in everything we do.”

He added, “While the unprecedented market challenges and uncertainties remain in the near-term, we will continue to stay focused on our strategy of driving superiority and productivity and enabled by the strength of our organization and culture to deliver balanced growth and value creation.”

Under FMCG companies Procter & Gamble Hygiene and Health Care are one of India’s fastest growing that has its portfolios Whisper is also a leading Feminine brand, and Vicks is India’s No 1 Health Care brand.